Short Interest in BioGaia AB (publ) (OTCMKTS:BIOGY) Rises By 367.9%

BioGaia AB (publ) (OTCMKTS:BIOGY) saw a significant growth in short interest in August. As of August 14th, there was short interest totaling 131 shares, a growth of 367.9% from the July 30th total of 28 shares. Based on an average daily volume of 52 shares, the short-interest ratio is currently 2.5 days.

BioGaia AB (publ) Price Performance

BIOGY opened at $12.45 on Thursday. The company’s 50 day simple moving average is $11.55 and its 200-day simple moving average is $11.19. BioGaia AB has a one year low of $9.64 and a one year high of $12.45.

BioGaia AB (publ) Company Profile

BioGaia AB (publ) is a Sweden-based biotechnology company specializing in the development, manufacturing and marketing of probiotic products for human and animal health. The company’s core research centers on select Lactobacillus reuteri strains, supported by extensive clinical studies to promote digestive wellness, immune support and oral health. BioGaia collaborates with academic institutions and healthcare organizations to translate scientific findings into consumer and medical applications.

BioGaia’s product portfolio includes probiotic drops, chewable tablets and oral health lozenges designed for infants, children and adults.